Medical Advisory Board
Meet the medical professionals who provide clinical oversight for the AI Blood Test Analyzer interpretation methodology. Kantesti provides informational support only and is not a medical device or a substitute for professional medical advice.
Excellence Through Expert Oversight
Our Medical Advisory Board comprises physicians, clinical pathologists, and laboratory medicine specialists who guide the development of our AI. Each member brings clinical experience in laboratory medicine.
The board meets quarterly to review algorithm performance, review new biomarker interpretation logic, and help keep the methodology current with the latest medical research and clinical guidelines. Their backgrounds span multiple specialties, supporting oversight of the interpretation methodology.
Last Updated: March 28, 2026
Executive Medical Leadership
Thomas Klein, MD
Chief Medical Officer (CMO)
Chief Medical Officer, Kantesti
Role at Kantesti
- Chief Medical Officer providing clinical oversight of the interpretation methodology
- Contributes to clinical documentation of the methodology
- Medical reviewer for AI methodology updates
- Liaison between Medical Advisory Board and development team
- Coordinates clinical oversight within the advisory board
Bio
Dr. Thomas Klein serves as Chief Medical Officer at Kantesti and provides clinical oversight for the AI blood test interpretation methodology. The platform provides informational support only and is not a medical device; it has not undergone independent or third-party clinical validation.
Medical Advisory Board Members
Our advisory board provides independent clinical oversight and guidance for AI algorithm development and validation.
Dr. Sarah Mitchell, MD, PhD
Chief Medical Advisor - Chair of Advisory Board
Bio
Dr. Sarah Mitchell serves as Chair of Kantesti's Medical Advisory Board and provides clinical oversight for the AI blood test interpretation methodology.
Prof. Dr. Hans Weber
Senior Medical Advisor - Laboratory Medicine
Bio
Prof. Dr. Hans Weber provides clinical oversight on Kantesti's Medical Advisory Board, with a focus on how laboratory variability and reference ranges are handled in the methodology.
Dr. Maria Rodriguez, MD, MPH
Medical Advisor - Internal Medicine
Bio
Dr. Maria Rodriguez contributes clinical oversight to Kantesti's Medical Advisory Board, with an interest in how biomarker information is presented in the methodology.
Dr. Chen Wei, MD, MSc
Medical Advisor - Endocrinology
Bio
Dr. Chen Wei contributes clinical oversight to Kantesti's Medical Advisory Board, with a focus on metabolic and hormone-related markers in the methodology.
Medical Advisory Board Inquiries
Experience Medical-Grade AI Analysis
Backed by world-class medical expertise, our AI delivers diagnostic insights you can trust